ArticleArchives of dermatological research2025

Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis).

Luca Potestio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.